Fortress Biotech, Inc.
NEW YORK, NY · Founded 2006 · CIK 0001429260 · Biotech · Public
Biopharmaceutical therapeutics and drug candidates acquired and developed for clinical advancement
fortressbiotech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $39M
- 9 Form D · Mar 2018
- 103 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 1 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092011201320152017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,240,000 | |
| Private capital raised | Form D · SEC | $7,000,000 | |
| Private capital raised | Form D · SEC | $3,989,940 | |
| Private capital raised | Form D · SEC | $14,118,534 | |
| Private capital raised | Form D · SEC | $68,500 | |
| Private capital raised | Form D · SEC | $82,200 | |
| Private capital raised | Form D · SEC | $2,733,839 | |
| Private capital raised | Form D · SEC | $3,254,000 | |
| Private capital raised | Form D · SEC | $6,517,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2291 | Xencor | — | $46M |
| 2292 | Perceive Biotherapeutics, Inc. | — | $40M |
| 2293 | HBVTECH | — | — |
| 2294 | Fortress Biotech, Inc. | — | $39M |
| 2295 | Tortugas Neuroscience | — | — |
| 2296 | FutureDerm Inc. | — | $468K |
| 2297 | SYNDEVRX INC | — | $38M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- George AvgerinosExecutive Officer
- David BarrettDirector
- Glenn CooperDirector · Executive Officer
- Gary GemignaniExecutive Officer
- Jimmie HarveyDirector
- Jimmie Harvey, Jr.Director
- Timothy HillmanExecutive Officer
- Malcolm HoenleinDirector
- Timothy HoferExecutive Officer
- Robyn HunterExecutive Officer
- Dov KleinDirector
- Bertrand LiangDirector
- J. LobellDirector
- Lucy LuExecutive Officer
- Elizabeth MooreExecutive Officer
- Stephen PilatzkeExecutive Officer
- Dale RitterExecutive Officer
- Linda RogersExecutive Officer
- Michael RogersDirector
- Lindsay RosenwaldDirector · Executive Officer
- Eric RowinskyDirector
- Bobby SandageDirector · Executive Officer
- Raymond TesiDirector · Executive Officer
- Michael WeissDirector · Executive Officer
- Peggy WentworthExecutive Officer
Patents
- Cyproterone Acetate Compositions And Uses Thereofapplication
- Cyproterone Acetate Compositions And Uses Thereofgranted
- Cyproterone Acetate Compositions And Uses Thereofapplication
- Cyproterone Acetate Compositions And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.